Dr Reddys Laboratories (RDY) Capital Expenditures (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded Capital Expenditures of -$25.11 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$59.88 million a year earlier.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Capital Expenditures (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' Capital Expenditures came in at $326.06 million as of Sep 30, 2026; for FY2026 (ended Mar 31, 2026), it was $249 million, down 22.7% from FY2025.
- Annual Capital Expenditures has a five-year compound annual growth rate of 13.4% (FY2021 to FY2026).
- Across earlier fiscal years, Capital Expenditures came in at $322 million in FY2025 (+63.5%), $197 million in FY2024 (+42.8%), $138 million in FY2023 (-28.5%) and $193 million in FY2022 (+45.1%).
- Quarterly Capital Expenditures has ranged from -$89.98 million in fiscal Q2 2025 to $387.36 million in fiscal Q4 2026 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$36.19 million (Q1 2027), $387.36 million (Q4 2026) and -$80.49 (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | -25.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -25.11 Mn |
| Jun 30, 2026 | -36.19 Mn |
| Mar 31, 2026 | 387.36 Mn |
| Dec 31, 2025 | -80.49 |
| Sep 30, 2025 | -59.88 Mn |
| Jun 30, 2025 | -80.17 Mn |
| Sep 30, 2024 | -89.98 Mn |
| Jun 30, 2024 | -61.26 Mn |
| Mar 31, 2024 | 331.89 Mn |
| Dec 31, 2023 | -46.07 Mn |
| Sep 30, 2023 | -44.57 Mn |
| Jun 30, 2023 | -44.29 Mn |
| Mar 31, 2023 | 244.08 Mn |
| Dec 31, 2022 | -35.63 Mn |
| Sep 30, 2022 | -31.49 Mn |
| Jun 30, 2022 | -42.86 Mn |
| Mar 31, 2022 | 340.18 Mn |
| Dec 31, 2021 | -55.23 Mn |
| Sep 30, 2021 | -48.33 Mn |
| Jun 30, 2021 | -43.40 Mn |
API Access
Dr Reddys Laboratories Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();